INTACEPT-25 MG

About

INTACEPT-25 MG contains a tumor necrosis factor (TNF) inhibitor, such as Etanercept, a dimeric fusion protein that binds to TNF-alpha, a key cytokine involved in inflammatory and immune responses. It is used to treat various autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. By neutralizing TNF-alpha, INTACEPT reduces inflammation and prevents the progression of joint damage in chronic inflammatory conditions.

This targeted biological therapy helps to alleviate pain, swelling, and stiffness, improving physical function and quality of life for patients. It is administered via subcutaneous injection, typically once or twice weekly, providing a convenient and effective treatment option for individuals suffering from these debilitating inflammatory disorders.

Uses

• Treatment of moderate to severe rheumatoid arthritis.
• Management of psoriatic arthritis.
• Therapy for ankylosing spondylitis.
• Treatment of moderate to severe plaque psoriasis.

Directions For Use

Administer via subcutaneous injection once or twice weekly, as directed by your physician. Rotate injection sites.

Benefits

• Reduces inflammation by neutralizing TNF-alpha.
• Alleviates joint pain, swelling, and stiffness.
• Slows the progression of joint damage.
• Improves physical function and quality of life.
• Effective in various chronic inflammatory conditions.
• Offers a targeted biological treatment option.

Side Effects

• Injection site reactions (pain, redness, swelling).
• Upper respiratory tract infections.
• Headache.
• Nausea.
• Diarrhea.
• Increased risk of serious infections (bacterial, fungal, viral).
• Reactivation of latent tuberculosis.
• New or worsening heart failure.
• Demyelinating disorders (e.g., multiple sclerosis) (rare).
• Malignancies (e.g., lymphoma, skin cancer) (rare).
• Autoimmune reactions (e.g., lupus-like syndrome).
• Pancytopenia (rare).

Safety Measures

• Alcohol - No specific interaction with alcohol, but general health advice to limit intake during illness or treatment applies.
• Pregnancy - INTACEPT is generally not recommended during pregnancy. Use only if clearly needed and the potential benefit outweighs the risk.
• Breastfeeding - It is unknown if INTACEPT is excreted in human milk. Consult your doctor; generally not recommended due to potential infant exposure.
• Liver - No specific dose adjustment is typically required for liver impairment.
• Kidney - No specific dose adjustment is typically required for renal impairment.
• Lung - Increased risk of serious infections, including tuberculosis and other opportunistic infections, which can affect the lungs. Monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.